Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

A Hydroxypyrone-Based Inhibitor of Metalloproteinase-12 Displays Neuroprotective Properties in Both Status Epilepticus and Optic Nerve Crush Animal Models.

Vinet J, Costa AM, Salinas-Navarro M, Leo G, Moons L, Arckens L, Biagini G.

Int J Mol Sci. 2018 Jul 25;19(8). pii: E2178. doi: 10.3390/ijms19082178.

2.

Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus.

Meletti S, Lucchi C, Monti G, Giovannini G, Bedin R, Trenti T, Rustichelli C, Biagini G.

J Neurochem. 2018 Jul 13. doi: 10.1111/jnc.14550. [Epub ahead of print]

PMID:
30005125
3.

High plasma levels of ghrelin and des-acyl ghrelin in responders to antiepileptic drugs.

Marchiò M, Roli L, Giordano C, Caramaschi E, Guerra A, Trenti T, Biagini G.

Neurology. 2018 Jul 3;91(1):e62-e66. doi: 10.1212/WNL.0000000000005741. Epub 2018 May 25.

PMID:
29802169
4.

Decreased ghrelin and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant epilepsy and maintained on the ketogenic diet.

Marchiò M, Roli L, Giordano C, Trenti T, Guerra A, Biagini G.

Clin Nutr. 2018 Mar 23. pii: S0261-5614(18)30121-3. doi: 10.1016/j.clnu.2018.03.009. [Epub ahead of print]

PMID:
29605572
5.

Electrographic Changes Accompanying Recurrent Seizures under Ketogenic Diet Treatment.

Lucchi C, Marchiò M, Caramaschi E, Giordano C, Giordano R, Guerra A, Biagini G.

Pharmaceuticals (Basel). 2017 Oct 20;10(4). pii: E82. doi: 10.3390/ph10040082.

6.

Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist.

Lucchi C, Costa AM, Giordano C, Curia G, Piat M, Leo G, Vinet J, Brunel L, Fehrentz JA, Martinez J, Torsello A, Biagini G.

Front Pharmacol. 2017 Sep 22;8:676. doi: 10.3389/fphar.2017.00676. eCollection 2017.

7.

Reduced steroidogenesis in patients with PCDH19-female limited epilepsy.

Trivisano M, Lucchi C, Rustichelli C, Terracciano A, Cusmai R, Ubertini GM, Giannone G, Bertini ES, Vigevano F, Gecz J, Biagini G, Specchio N.

Epilepsia. 2017 Jun;58(6):e91-e95. doi: 10.1111/epi.13772. Epub 2017 May 4.

8.

Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.

Molteni L, Rizzi L, Bresciani E, Possenti R, Petrocchi Passeri P, Ghè C, Muccioli G, Fehrentz JA, Verdié P, Martinez J, Omeljaniuk RJ, Biagini G, Binda A, Rivolta I, Locatelli V, Torsello A.

Front Pharmacol. 2017 Mar 30;8:167. doi: 10.3389/fphar.2017.00167. eCollection 2017.

9.

Progressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in Neurons.

Giordano C, Costa AM, Lucchi C, Leo G, Brunel L, Fehrentz JA, Martinez J, Torsello A, Biagini G.

Front Cell Neurosci. 2016 Dec 16;10:281. doi: 10.3389/fncel.2016.00281. eCollection 2016.

10.

MicroRNA-101 Regulates Multiple Developmental Programs to Constrain Excitation in Adult Neural Networks.

Lippi G, Fernandes CC, Ewell LA, John D, Romoli B, Curia G, Taylor SR, Frady EP, Jensen AB, Liu JC, Chaabane MM, Belal C, Nathanson JL, Zoli M, Leutgeb JK, Biagini G, Yeo GW, Berg DK.

Neuron. 2016 Dec 21;92(6):1337-1351. doi: 10.1016/j.neuron.2016.11.017. Epub 2016 Dec 8.

11.

JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.

Bresciani E, Rizzi L, Molteni L, Ravelli M, Liantonio A, Ben Haj Salah K, Fehrentz JA, Martinez J, Omeljaniuk RJ, Biagini G, Locatelli V, Torsello A.

Endocrine. 2017 Oct;58(1):106-114. doi: 10.1007/s12020-016-1184-2. Epub 2016 Nov 28.

PMID:
27896546
12.

Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus.

Meletti S, Lucchi C, Monti G, Giovannini G, Bedin R, Trenti T, Rustichelli C, Biagini G.

Epilepsia. 2017 Feb;58(2):e16-e20. doi: 10.1111/epi.13625. Epub 2016 Nov 26.

13.

Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus.

Vinet J, Vainchtein ID, Spano C, Giordano C, Bordini D, Curia G, Dominici M, Boddeke HW, Eggen BJ, Biagini G.

Glia. 2016 Aug;64(8):1350-62. doi: 10.1002/glia.23008. Epub 2016 Jun 1.

PMID:
27246930
14.

Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/ΔFosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the Hippocampus.

Giordano C, Vinet J, Curia G, Biagini G.

PLoS One. 2015 Nov 10;10(11):e0141221. doi: 10.1371/journal.pone.0141221. eCollection 2015.

15.

Ischemic-hypoxic mechanisms leading to hippocampal dysfunction as a consequence of status epilepticus.

Lucchi C, Vinet J, Meletti S, Biagini G.

Epilepsy Behav. 2015 Aug;49:47-54. doi: 10.1016/j.yebeh.2015.04.003. Epub 2015 Apr 29.

PMID:
25934585
16.

Blockade of in vitro ictogenesis by low-frequency stimulation coincides with increased epileptiform response latency.

Kano T, Inaba Y, D'Antuono M, Biagini G, Levésque M, Avoli M.

J Neurophysiol. 2015 Jul;114(1):21-8. doi: 10.1152/jn.00248.2015. Epub 2015 Apr 29.

17.

Activity-dependent changes in excitability of perirhinal cortex networks in vitro.

Biagini G, D'Antuono M, Inaba Y, Kano T, Ragsdale D, Avoli M.

Pflugers Arch. 2015 Apr;467(4):805-16. doi: 10.1007/s00424-014-1545-8. Epub 2014 Jun 7.

18.

Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Giordano C, Marchiò M, Timofeeva E, Biagini G.

Front Neurol. 2014 Apr 29;5:63. doi: 10.3389/fneur.2014.00063. eCollection 2014. Review.

19.

Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus.

Lucchi C, Curia G, Vinet J, Gualtieri F, Bresciani E, Locatelli V, Torsello A, Biagini G.

PLoS One. 2013 Aug 28;8(8):e72716. doi: 10.1371/journal.pone.0072716. eCollection 2013.

20.

Perirhinal cortex and temporal lobe epilepsy.

Biagini G, D'Antuono M, Benini R, de Guzman P, Longo D, Avoli M.

Front Cell Neurosci. 2013 Aug 29;7:130. doi: 10.3389/fncel.2013.00130. Review.

Supplemental Content

Loading ...
Support Center